About Us
Boss Profile
Wu, academician of the Chinese Academy of engineering, famous Chinese cardiovascular disease experts, the Collaterals Disease science discipline founder and leader, chief scientist of the national 973 project,, director of the State Key Laboratory of collateral disease research and innovation of traditional Chinese medicine, vice chairman of the National Committee of experts of cardiovascular disease center, director of the State Administration of traditional Chinese medicine collateral disease of key research laboratory, he served as integrated traditional Chinese and Western medicine combined with the vice president of the society, China Association of Chinese medicine, vice president of the association of Chinese medicine will be collateral disease branch of the chairman of the Committee.

Founded in 1992, Yiling pharmaceutical. Good TCM theory of collateral disease and coronary heart disease, arrhythmia, chronic heart failure, stroke and other cardiovascular disease diagnosis and treatment. Has obtained 5 national science and technology award, won the 2008 annual "HLHL fund of science and technology innovation award".

The creation of a new discipline of collateral disease, Chinese medicine really go out, Yiling pharmaceutical is the dream of many years. In June 2012, the World Association of Chinese Medicine Association Professional Committee of collateral disease in Beijing was established and the establishment of a committee of collateral disease in 28 provinces of China, Europe, Canada and Taiwan Institute of collateral disease was established and has been extended to more than 20 countries and regions. Since 2005, the 11 International Conference on the disease of the world has been held continuously.

Original, under the leadership of Professor Wu Yiling collateral disease theory development of the four milestones: is the representative study of collateral disease theory has made great achievements: first to construct the system of theoretical system, the creation of the TCM collateral disease study of new disciplines and advantages of disciplines, editor of the publication of the collateral disease "," context theory monograph, in Professor Wu to collateral disease theory to guide the development of the Tongxinluo capsule, Shensong Yangxin Capsule Qili Qiangxin Capsule, even the flower Qingwen capsule 10 Chinese patent, the collateral disease theory led to the patent Chinese medicine research and development and industrialization development, traditional Chinese medicine known as the Collaterals Disease development history since the spring and Autumn period, the Han Dynasty, the Qing Dynasty after the fourth mileage.

Academician Wu Yiling as a representative of the intangible cultural heritage of our province, he created the "traditional Chinese medicine treatment method" was identified as a national intangible cultural heritage.

Message to this supplier

Copyright © Yiling Company Group ( Yiling Hospital&Yiling Health Center&Yiling Travel Agency) All rights reserved.